Literature DB >> 10571026

Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology.

C A Lingwood1.   

Abstract

Eukaryotic cell surface glycolipids can act as both the primary interface between bacteria and their host and secondly as a targeting mechanism for bacterial virulence factors. The former is characterized by redundancy in adhesin-receptor interactions and the latter by a higher affinity, more restrictive glycolipid binding specificity for targeting. Interactions of verotoxin with its glycolipid receptor globotriaosylceramide and Helicobacter pylori binding to a variety of different glycolipids, which can be environmentally regulated, provide examples of these differing modes of glycolipid receptor function. Verotoxins are involved in endothelial targeting in the microangiopathies of hemorrhagic colitis and hemolytic uremic syndrome (HUS). The highly restricted binding specificity and crystal structure of the verotoxin B subunit have allowed theoretical modeling of the Gb3 binding site of the verotoxin B subunit pentamer which provides an approach to intervention. Studies of the role of glycolipid function in verotoxin-induced disease have concentrated on the distribution of Gb3 and its ability to mediate the internalization of the toxin within the target cell. The distribution of Gb3 within the renal glomerulus plays a central role in defining the age-related etiology of HUS following gastrointestinal infection with VT producing Escherichia coli. H. pylori, on the other hand, instigates a less distinct but more complex disseminated gastric inflammation. Studies on the role of glycolipid receptors in H. pylori infection have been bogged down in establishing the importance of each binding specificity defined. In addition, the physiological condition of the organism within the various binding assays has not been extensively considered, such that spurious non-physiological interactions may have been elucidated. The identification and cloning of a Le(b) binding adhesin and the identification of cell surface hsp70 as a mediator of sulfoglycolipid binding under stress conditions may now allow a more molecular approach to define the role of glycolipid recognition in this infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571026     DOI: 10.1016/s0925-4439(99)00062-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  Bartonella henselae induces NF-kappaB-dependent upregulation of adhesion molecules in cultured human endothelial cells: possible role of outer membrane proteins as pathogenic factors.

Authors:  O Fuhrmann; M Arvand; A Göhler; M Schmid; M Krüll; S Hippenstiel; J Seybold; C Dehio; N Suttorp
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 2.  Remodeling of sphingolipids by plasma membrane associated enzymes.

Authors:  Massimo Aureli; Nicoletta Loberto; Vanna Chigorno; Alessandro Prinetti; Sandro Sonnino
Journal:  Neurochem Res       Date:  2010-12-23       Impact factor: 3.996

3.  Shiga toxin regulates its entry in a Syk-dependent manner.

Authors:  Silje Ugland Lauvrak; Sébastien Wälchli; Tore-Geir Iversen; Hege Holte Slagsvold; Maria Lyngaas Torgersen; Bjørn Spilsberg; Kirsten Sandvig
Journal:  Mol Biol Cell       Date:  2005-12-21       Impact factor: 4.138

Review 4.  Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum.

Authors:  Maria Teresa Tarragó-Trani; Brian Storrie
Journal:  Adv Drug Deliv Rev       Date:  2007-06-28       Impact factor: 15.470

5.  Bimodal Response to Shiga Toxin 2 Subtypes Results from Relatively Weak Binding to the Target Cell.

Authors:  Patrick Cherubin; Dennis Fidler; Beatriz Quiñones; Ken Teter
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

6.  Molecular dynamics study of the conformations of glycosidic linkages in sialic acid modified ganglioside GM3 analogues.

Authors:  G Jaishree; D Jeya Sundara Sharmila
Journal:  Glycoconj J       Date:  2014-06-10       Impact factor: 2.916

7.  In vitro binding of Helicobacter pylori to monohexosylceramides.

Authors:  M Abul-Milh; D Barnett Foster; C A Lingwood
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

8.  Divergent mechanisms of interaction of Helicobacter pylori and Campylobacter jejuni with mucus and mucins.

Authors:  Julie Ann Naughton; Karina Mariño; Brendan Dolan; Colm Reid; Ronan Gough; Mary E Gallagher; Michelle Kilcoyne; Jared Q Gerlach; Lokesh Joshi; Pauline Rudd; Stephen Carrington; Billy Bourke; Marguerite Clyne
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

9.  Escherichia coli shiga-like toxins induce apoptosis and cleavage of poly(ADP-ribose) polymerase via in vitro activation of caspases.

Authors:  Joyce C Y Ching; Nicola L Jones; Peter J M Ceponis; Mohamed A Karmali; Philip M Sherman
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Interplay between toxin transport and flotillin localization.

Authors:  Sascha Pust; Anne Berit Dyve; Maria L Torgersen; Bo van Deurs; Kirsten Sandvig
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.